| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 693.71M | 648.43M | 661.54M | 594.10M | 1.19B | 1.06B |
| Gross Profit | 68.31M | 61.70M | 67.80M | 62.61M | 72.84M | 57.42M |
| EBITDA | 30.49M | 27.09M | 23.15M | 31.73M | 15.51M | 19.00M |
| Net Income | 15.65M | 29.48M | -1.27M | -8.34M | -6.25M | -11.82M |
Balance Sheet | ||||||
| Total Assets | 301.25M | 292.25M | 301.12M | 386.85M | 385.75M | 445.40M |
| Cash, Cash Equivalents and Short-Term Investments | 63.75M | 61.16M | 57.03M | 2.09M | 2.06M | 1.89M |
| Total Debt | 24.20M | 22.58M | 25.92M | 65.55M | 66.29M | 109.22M |
| Total Liabilities | 93.25M | 83.69M | 99.34M | 176.63M | 162.38M | 218.52M |
| Stockholders Equity | 206.42M | 206.94M | 200.33M | 208.84M | 223.37M | 225.51M |
Cash Flow | ||||||
| Free Cash Flow | 28.63M | 19.39M | 21.53M | -25.16M | 40.46M | 2.13M |
| Operating Cash Flow | 30.07M | 21.54M | 24.42M | -14.47M | 50.23M | 13.57M |
| Investing Cash Flow | 81.56M | -2.15M | 80.11M | -10.69M | 8.68M | -9.36M |
| Financing Cash Flow | -49.01M | -15.27M | -50.35M | 24.88M | -58.63M | -5.41M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | $409.53M | 15.44 | 15.15% | 3.55% | 9.33% | 72.31% | |
72 Outperform | $896.23M | 23.19 | 6.65% | ― | 12.68% | 3.09% | |
71 Outperform | $403.13M | 20.41 | 9.72% | 3.70% | -5.33% | ― | |
71 Outperform | $1.96B | 27.02 | 5.85% | 1.44% | 2.19% | -39.07% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
56 Neutral | $116.17M | -2.52 | -17.40% | ― | 4.10% | -2241.30% | |
52 Neutral | $2.11B | -21.13 | -6.37% | ― | 1.45% | -5.49% |
On January 14, 2026, Calavo Growers agreed to be acquired by Mission Produce through a two-step merger in which Calavo shareholders will receive 0.9790 Mission shares plus $14.85 in cash per Calavo share, with mechanisms to preserve the intended U.S. tax reorganization treatment by adjusting the stock/cash mix if needed. The deal, which remains subject to shareholder approvals, antitrust and other regulatory clearances, Nasdaq listing of new Mission shares and effectiveness of a registration statement, will see all Calavo stock options and restricted stock units vest and be cashed out based on the merger consideration value, and one Calavo independent director will join the Mission board at closing. The merger agreement includes customary covenants, non-solicitation provisions and detailed termination rights, including a Calavo break-up fee of about $12.87 million in certain circumstances and reverse termination fees payable by Mission of about $15.02 million or $12.87 million depending on the reason for termination, underscoring the strategic significance and negotiated protections around consolidation in the avocado and fresh foods sector. On the same date, Calavo entered into executive retention agreements with CFO James Snyder and Calavo Foods EVP Ronald Araiza, providing sizable one-time retention bonuses, change-in-control bonuses and severance protections to stabilize leadership through the transaction, and the board signaled it does not expect to hold a 2026 annual meeting in order to focus on timely completion of the merger.
The most recent analyst rating on (CVGW) stock is a Buy with a $25.00 price target. To see the full list of analyst forecasts on Calavo Growers stock, see the CVGW Stock Forecast page.
On December 22, 2025, Calavo Growers, Inc. announced that it had received a letter from the staff of the U.S. Securities and Exchange Commission stating that the SEC staff had concluded its previously disclosed investigation into the company and, based on the information available at that time, did not intend to recommend any enforcement action. The closure of the probe, which had been detailed in earlier regulatory filings including Calavo’s Form 10-K for the fiscal year ended October 31, 2024, removes a regulatory overhang for the company and its stakeholders, easing concerns about potential sanctions or litigation risk tied to the investigation.
The most recent analyst rating on (CVGW) stock is a Hold with a $21.50 price target. To see the full list of analyst forecasts on Calavo Growers stock, see the CVGW Stock Forecast page.
On December 8, 2025, Lecil E. Cole retired as the President and CEO of Calavo Growers, Inc. On his retirement, an agreement was made to amend his stock options, allowing for the vesting and exercisability of 300,000 shares. The agreement also includes a right of first offer for Calavo Growers to purchase avocados grown by Mr. Cole or his affiliates, impacting the company’s operations and supply chain.
The most recent analyst rating on (CVGW) stock is a Hold with a $21.50 price target. To see the full list of analyst forecasts on Calavo Growers stock, see the CVGW Stock Forecast page.
On November 19, 2025, Mike Browne announced his retirement from Calavo Growers, Inc., where he served as Executive Vice President of Sales and Operations. His retirement will be effective December 1, 2025.
The most recent analyst rating on (CVGW) stock is a Hold with a $19.00 price target. To see the full list of analyst forecasts on Calavo Growers stock, see the CVGW Stock Forecast page.
On November 12, 2025, Calavo Growers announced the retirement of Lee E. Cole as President and CEO, effective December 8, 2025, after four decades of leadership. B. John Lindeman, a current board member and former CFO of Calavo, will succeed him. Lindeman’s appointment is expected to leverage his extensive industry knowledge and strategic insight to advance Calavo’s strategic priorities and create sustainable value for shareholders. The company is also evaluating strategic alternatives following a non-binding proposal to acquire all outstanding shares, with the review process ongoing.
The most recent analyst rating on (CVGW) stock is a Hold with a $24.00 price target. To see the full list of analyst forecasts on Calavo Growers stock, see the CVGW Stock Forecast page.